Related Experiment Video
Updated: Mar 26, 2026

A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells
Published on: August 7, 2017
Mesenchymal stem cell-based therapy in kidney transplantation
1Department of Urology, The First Affiliated Hospital of Soochow University, 188 Shizi Road, Suzhou, 215006, Jiangsu, PR China.
Abstract:
Kidney transplantation is the best treatment for end-stage renal disease, but its implementation is limited by organ shortage and immune rejection. Side effects of current immunosuppressive drugs, such as nephrotoxicity, opportunistic infection, and tumorigenic potential, influence long-term graft outcomes. In recent years, continued research and subsequent discoveries concerning the properties and potential utilization of mesenchymal stem cells (MSCs) have aroused considerable interest and expectations. Biological characteristics of MSCs, including multi-lineage differentiation, homing potential, paracrine effect and immunomodulation, have opened new horizons for applications in kidney transplantation. However, many studies have shown that the biological activity of MSCs depends on internal inflammatory conditions, and the safety and efficacy of the clinical application of MSCs remain controversial. This review summarizes the findings of a large number of studies and aims to provide an objective viewpoint based on a comprehensive analysis of the presently established benefits and obstacles of implementing MSC-based therapy in kidney transplantation, and to promote its clinical translation.
Insights
Mesenchymal stem cells (MSCs) show promise for kidney transplantation by modulating immune responses. However, their clinical use requires further research to overcome challenges related to safety and efficacy in diverse inflammatory environments.
Area of Science:
- Nephrology
- Regenerative Medicine
- Immunology
Background:
- Kidney transplantation is optimal for end-stage renal disease but faces organ shortages and immune rejection.
- Current immunosuppressants have significant side effects impacting long-term graft survival.
- Mesenchymal stem cells (MSCs) offer potential therapeutic benefits due to their unique biological properties.
Purpose of the Study:
- To review the benefits and obstacles of using MSCs in kidney transplantation.
- To provide an objective viewpoint on MSC-based therapy for kidney transplant recipients.
- To promote the clinical translation of MSCs in this field.
Main Methods:
- Comprehensive literature review of studies on MSCs and kidney transplantation.
- Analysis of MSC biological characteristics: differentiation, homing, paracrine effects, and immunomodulation.
- Evaluation of factors influencing MSC activity, including inflammatory conditions.
Main Results:
- MSCs possess properties beneficial for kidney transplantation, including immunomodulation and potential tissue repair.
- MSC efficacy and safety in clinical settings are debated, influenced by internal inflammatory states.
- Existing research highlights both promise and challenges for MSC application.
Conclusions:
- MSC-based therapy presents a promising avenue for improving kidney transplant outcomes.
- Addressing the variability in MSC biological activity and ensuring clinical safety are critical.
- Further research is essential to optimize MSC therapy for widespread clinical adoption.
More Related Videos
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Mesenchymal Stem Cells
Kidney Transplant I: Introduction

